BriaCell Therapeutics Corp. (NASDAQ:BCTXW) Short Interest Up 100.0% in September

BriaCell Therapeutics Corp. (NASDAQ:BCTXW) saw a significant growth in short interest in September. As of September 15th, there was short interest totaling 800 shares, a growth of 100.0% from the August 31st total of 400 shares. Based on an average daily trading volume, of 57,300 shares, the days-to-cover ratio is currently 0.0 days. Based on an average daily trading volume, of 57,300 shares, the days-to-cover ratio is currently 0.0 days.

BriaCell Therapeutics Stock Up 7.3%

Shares of BCTXW opened at $0.04 on Monday. The firm’s 50 day moving average is $0.03 and its 200-day moving average is $0.06. BriaCell Therapeutics has a 12 month low of $0.01 and a 12 month high of $0.70.

BriaCell Therapeutics Company Profile

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers.